These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10910080)

  • 1. Identification and fine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancer susceptibility locus.
    Paris PL; Witte JS; Kupelian PA; Levin H; Klein EA; Catalona WJ; Casey G
    Cancer Res; 2000 Jul; 60(13):3645-9. PubMed ID: 10910080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer aggressiveness locus on chromosome segment 19q12-q13.1 identified by linkage and allelic imbalance studies.
    Neville PJ; Conti DV; Krumroy LM; Catalona WJ; Suarez BK; Witte JS; Casey G
    Genes Chromosomes Cancer; 2003 Apr; 36(4):332-9. PubMed ID: 12619157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies.
    Neville PJ; Conti DV; Paris PL; Levin H; Catalona WJ; Suarez BK; Witte JS; Casey G
    Neoplasia; 2002; 4(5):424-31. PubMed ID: 12192601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.
    Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R
    Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer.
    Jenkins R; Takahashi S; DeLacey K; Bergstralh E; Lieber M
    Genes Chromosomes Cancer; 1998 Feb; 21(2):131-43. PubMed ID: 9491325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide scan of brothers: replication and fine mapping of prostate cancer susceptibility and aggressiveness loci.
    Witte JS; Suarez BK; Thiel B; Lin J; Yu A; Banerjee TK; Burmester JK; Casey G; Catalona WJ
    Prostate; 2003 Dec; 57(4):298-308. PubMed ID: 14601026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
    Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O
    Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct regions of allelic loss on 13q in prostate cancer.
    Cooney KA; Wetzel JC; Merajver SD; Macoska JA; Singleton TP; Wojno KJ
    Cancer Res; 1996 Mar; 56(5):1142-5. PubMed ID: 8640774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a prostate cancer susceptibility locus on the X chromosome.
    Xu J; Meyers D; Freije D; Isaacs S; Wiley K; Nusskern D; Ewing C; Wilkens E; Bujnovszky P; Bova GS; Walsh P; Isaacs W; Schleutker J; Matikainen M; Tammela T; Visakorpi T; Kallioniemi OP; Berry R; Schaid D; French A; McDonnell S; Schroeder J; Blute M; Thibodeau S; Grönberg H; Emanuelsson M; Damber JE; Bergh A; Jonsson BA; Smith J; Bailey-Wilson J; Carpten J; Stephan D; Gillanders E; Amundson I; Kainu T; Freas-Lutz D; Baffoe-Bonnie A; Van Aucken A; Sood R; Collins F; Brownstein M; Trent J
    Nat Genet; 1998 Oct; 20(2):175-9. PubMed ID: 9771711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
    Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
    Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity of the putative prostate cancer susceptibility gene HPC2/ELAC2 is uncommon in sporadic and familial prostate cancer.
    Wu YQ; Chen H; Rubin MA; Wojno KJ; Cooney KA
    Cancer Res; 2001 Dec; 61(24):8651-3. PubMed ID: 11751379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prohibitin mutations are uncommon in prostate cancer families linked to chromosome 17q.
    White KA; Lange EM; Ray AM; Wojno KJ; Cooney KA
    Prostate Cancer Prostatic Dis; 2006; 9(3):298-302. PubMed ID: 16733518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic imbalance in hereditary and sporadic prostate cancer.
    Verhage BA; van Houwelingen K; Ruijter TE; Kiemeney LA; Schalken JA
    Prostate; 2003 Jan; 54(1):50-7. PubMed ID: 12481255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of tumor metastasis suppressor region on the short arm of human chromosome 20.
    Goodarzi G; Mashimo T; Watabe M; Cuthbert AP; Newbold RF; Pai SK; Hirota S; Hosobe S; Miura K; Bandyopadhyay S; Gross SC; Balaji KC; Watabe K
    Genes Chromosomes Cancer; 2001 Sep; 32(1):33-42. PubMed ID: 11477659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q.
    Yin Z; Babaian RJ; Troncoso P; Strom SS; Spitz MR; Caudell JJ; Stein JD; Kagan J
    Oncogene; 2001 Apr; 20(18):2273-80. PubMed ID: 11402322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a tumor suppressor gene distal to BRCA1 in prostate cancer.
    Williams BJ; Jones E; Zhu XL; Steele MR; Stephenson RA; Rohr LR; Brothman AR
    J Urol; 1996 Feb; 155(2):720-5. PubMed ID: 8558713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic imbalance and microsatellite instability in prostatic adenocarcinoma.
    Cunningham JM; Shan A; Wick MJ; McDonnell SK; Schaid DJ; Tester DJ; Qian J; Takahashi S; Jenkins RB; Bostwick DG; Thibodeau SN
    Cancer Res; 1996 Oct; 56(19):4475-82. PubMed ID: 8813143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion mapping suggests that the 1p22 melanoma susceptibility gene is a tumor suppressor localized to a 9-Mb interval.
    Walker GJ; Indsto JO; Sood R; Faruque MU; Hu P; Pollock PM; Duray P; Holland EA; Brown K; Kefford RF; Trent JM; Mann GJ; Hayward NK
    Genes Chromosomes Cancer; 2004 Sep; 41(1):56-64. PubMed ID: 15236317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13.
    Fiedler U; Ehlers W; Meye A; Füssel S; Faller G; Schmidt U; Wirth MP
    Anticancer Res; 2001; 21(4A):2341-50. PubMed ID: 11724291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xq27-28 deletions in prostate carcinoma.
    Kibel AS; Faith DA; Bova GS; Isaacs WB
    Genes Chromosomes Cancer; 2003 Aug; 37(4):381-8. PubMed ID: 12800149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.